A Phase II Study of Arsenic Trioxide in Combination With Thalidomide, Dexamethasone, and Ascorbic Acid.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Arsenic trioxide; Ascorbic acid; Dexamethasone; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 May 2012 Biomarkers information updated
- 07 Jun 2010 Planned end date (1 Feb 2006) added as reported by ClinicalTrials.gov.
- 07 Jun 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.